Sysmex (OTCMKTS:SSMXY) Announces Quarterly Earnings Results

Sysmex (OTCMKTS:SSMXY) posted its earnings results on Tuesday. The company reported $0.10 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.10, Zacks reports. Sysmex had a return on equity of 8.01% and a net margin of 7.62%. Sysmex updated its FY 2026 guidance to 0.415-0.415 EPS.

Sysmex Stock Up 0.1%

Shares of Sysmex stock traded up $0.02 on Tuesday, reaching $13.57. 515 shares of the company were exchanged, compared to its average volume of 216,702. The company has a current ratio of 3.40, a quick ratio of 2.53 and a debt-to-equity ratio of 0.23. The company has a market capitalization of $8.25 billion, a price-to-earnings ratio of 32.30 and a beta of 1.20. The company has a 50-day moving average of $12.01 and a 200 day moving average of $10.03. Sysmex has a one year low of $8.01 and a one year high of $13.57.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Sysmex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 18th. Two analysts have rated the stock with a Hold rating. According to MarketBeat, Sysmex presently has a consensus rating of “Hold”.

About Sysmex

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis.

The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.